Executives at Rhythm Pharmaceuticals and RIT Capital Partners sell shares

Rhythm Pharmaceuticals Executive Vice President Yann Mazabraud sold 57,000 shares of the company on August 12th. The transaction, executed under a pre-arranged Rule 10b5-1 trading plan, had an average price of $116.15, totaling approximately $6,620,550. Following the sale, Mazabraud holds 55,655 shares.

Separately, Hannah Rothschild sold 24,365 shares of RIT Capital Partners on August 6th. The shares were sold at an average price of GBX 2,600, resulting in proceeds of approximately £633,490. RIT Capital Partners is a self-managed investment trust based in London.